| Acronym |
Definition |
| 45 CFR 46 |
Code of Federal Regulation |
| AAMC |
American Association of Medical Colleges |
| AE |
Adverse Event |
| BSL |
Biosafety Level |
| CCM |
Center for Comparative Medicine |
| CDC |
Centers for Disease Control and Prevention |
| CFR |
Code of Federal Regulations |
| CITI |
Collaborative Institutional Training Initiative |
| CMC |
Contaminated Materials Container |
| COI |
Conflict of Interest |
| CIOMS |
Council for International Organizations of Medical Sciences |
| CRA |
Clinical Research Associate |
| CRC |
Clinical Research Coordinator |
| CTC |
Clinical Trials Coordinator or Clinical Trials Office |
| DEA |
Drug Enforcement Administration |
| DEQ |
Department of Environmental Quality |
| DHEW |
Department of Health, Education and Welfare |
| DHHS |
Department of Health and Human Services |
| DOD |
U.S. Department of Defense |
| DOR |
Division of Research |
| DSMB |
Data and Safety Monitoring Board |
| DSMP |
Data and Safety Monitoring Plan |
| EH&S |
Environmental Health and Safety |
| EPA |
Environmental Protection Agency |
| FDA |
Food and Drug Administration |
| FOIA |
Freedom of Information Act |
| FWA |
Federal Wide Assurance |
| GCP |
Good Clinical Practice |
| GCRC |
General Clinical Research Center |
| GLP |
Good Laboratory Practices |
| GMP |
Good Manufacturing Practice |
| HHS |
Health and Human Services |
| HIPAA |
Health Insurance Portability and Accountability Act |
| IACUC |
Institutional Animal Care and Use Committee |
| IBC |
Institutional Biosafety Committee |
| ICF |
Informed Consent Form |
| IDE |
Investigational Device Exemptions |
| IND |
Investigational New Drug Application |
| IO |
Institutional Official |
| IRB |
Institutional Review Board |
| IRB-HS |
Health Sciences IRB |
| IRB-SB |
Social and Behavioral IRB |
| LAR |
Legally Authorized Representative |
| MTA |
Material Transfer Agreement |
| NABR |
National Association for Biomedical Research |
| NBAC |
National Bioethics Advisory Commission |
| NCI |
National Cancer Institute |
| NCI-CIRB |
National Cancer Institute Central Institutional Review Board |
| NCI-PCIRB |
National Cancer Institute Pediatric Central Inst. Review Board |
| NDA |
New Drug Application |
| NGA |
Notice of Grant Award |
| NIH |
National Institutes of Health |
| NIH-NRSA |
National Research Service Award |
| NLM |
National Library of Medicine |
| NRC |
Nuclear Regulatory Commission |
| NRC |
National Research Council |
| NSF |
National Science Foundation |
| OHRP |
Office for Human Research Protections |
| OMB |
Office of Management and Budget |
| ORED |
Office of Research and Economic Development |
| ORI |
Office of Research Integrity |
| PHI |
Protected Health Information |
| PHRP |
Partnership for Human Research Protection, Inc. |
| PHS |
Public Health Service |
| PI |
Principal Investigator |
| PRIM&R |
Public Responsibility in Medicine and Research |
| RCR |
Responsible Conduct of Research |
| SAE |
Serious Adverse Event |
| SOP |
Standard Operating Procedures |
| USDA |
United States Department of Agriculture |
